Oncocyte corporation announces $10.2 million private placement of securities priced at-the-market under nasdaq rules

Company obtains participation from new and existing investors, including strategic partner bio-rad laboratories company obtains participation from new and existing investors, including strategic partner bio-rad laboratories
NDAQ Ratings Summary
NDAQ Quant Ranking